Why RH, SecureWorks, and Aurinia Pharmaceuticals Jumped Today
Find out what made one of these stocks truly skyrocket.
Aurinia Pharmaceuticals
AUPH
AUPH
$15.78
$0.34
2.2%
BATS BZX Real Time Price as of December 9, 2019, 4:00 p.m. EST
View Interactive AUPH Charts
Aurinia Pharmaceuticals Inc
News & Analysis: Aurinia Pharmaceuticals
Why Aurinia Pharmaceuticals Stock Is Skyrocketing Today
Aurinia's experimental lupus med hit pay dirt in a large, pivotal-stage trial.
Here’s Why Aurinia Pharmaceuticals Stock Jumped Higher Today
Results of a phase 3 clinical trial are imminent for the biotech.
Why Aurinia Pharmaceuticals Is Soaring Today
Traders are feeling bullish after management provides investors with clinical and financial updates.
Why Aurinia Pharmaceuticals' Stock Is Up Big Today
Shares jump after a Wall Street pro turns bullish.
Aurinia Pharmaceuticals Inc (AUPH) Q4 2018 Earnings Conference Call Transcript
AUPH earnings call for the period ending December 31, 2018.
Here's Why Aurinia Pharmaceuticals' Stock Jumped Today
It looks like an important patent that could protect its lead candidate is a done deal.
Is Aurinia Pharmaceuticals a Buy?
The pharma company bounced around for much of 2018, but there's intriguing potential in the pipeline.
These Small Cap Biopharma Stocks Lost as Much as 34.1% in October. Are They Buys?
Stock market slides are rarely kind to development-stage biopharma companies. Did October's sell-off create any opportunities for investors?
Here's What Pushed Aurinia Pharmaceuticals Inc. Up 16.8% in September
Steady progress for the company's experimental lupus treatment took an important step forward
